Lenalidomide as a Potent Inducer of Graft Versus Leukemia Effect in Patients with Hematologic Malignancies at High Risk of Relapse Post Allogeneic Stem Cell Transplant
Source: Indian Journal of Hematology and Blood Transfusion - Category: Hematology Source Type: research
More News: Blood Transusion | Cancer & Oncology | Hematology | India Health | Leukemia | Revlimid | Stem Cell Therapy | Stem Cells | Transplants